psychedelic patents

Enveric Biosciences Inc (NASDAQ:ENVB), a biotechnology company focused on neuropsychiatric treatment development, has secured five new U.S. patents for its EVM301 portfolio. This latest additions bring Enveric's total to nine issued U.S. patents, enhancing the intellectual property surrounding its...

Clearmind Medicine Inc. (NASDAQ:CMND), a clinical-stage biotech firm based in Vancouver, has been granted a new patent by the United States Patent and Trademark Office. As the company stated in a press release, this approval marks a significant milestone in Clearmind's efforts to develop...

As Reunion Neuroscience (NASDAQ: REUN) and Mindset Pharma (OTCMKTS: MSSTF) continue their court battle over claims on a novel 4-OH-DiPT prodrug, private biotech company Terran Biosciences has also filed a patent application over a proprietary polymorph, reported Noah Smith. 4-HO-DiPT is a...

This article by Jennifer Walker-Journey was originally published on Psychedelic Spotlight, and appears here with permission. Mounting clinical research is demonstrating that psychedelic therapies are a game-changer when it comes to mental health treatment. And recent ...